| Antibodies, epicenter of SARS-CoV-2 immunology #MMPMID33500559Pecetta S; Pizza M; Sala C; Andreano E; Pileri P; Troisi M; Pantano E; Manganaro N; Rappuoli RCell Death Differ 2021[Feb]; 28 (2): 821-824 PMID33500559show ga
ä|Antibodies, Neutralizing/*immunology/therapeutic use[MESH]|Antibodies, Viral/*immunology/therapeutic use[MESH]|COVID-19 Serotherapy[MESH]|COVID-19/epidemiology/*immunology/prevention & control/therapy[MESH]|Humans[MESH]|Immunization, Passive[MESH]|SARS-CoV-2/*immunology[MESH]
DeepDyve Pubget Overpricing |
|